| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 79,484 |
-
| | Cost of Revenue | 63,274 |
-
| | | Gross Profit | 16,210 |
-
| | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 3,276 | 20 | | Non Recurring | 1,753 |
-
| | Others | 389 |
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 10,792 | (20) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 93 |
-
| | Earnings Before Interest And Taxes | 10,885 | (20) | | Interest Expense | 251 | 4 | | Income Before Tax | 10,634 | (24) | | Income Tax Expense | 2,151 |
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 8,483 | (24) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 8,483 | (24) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $8,483 | ($24) |
|
0.51% Nasdaq 
0.04 (1.05%) 
Income Statement
